Detalhe da pesquisa
1.
Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant.
N Engl J Med
; 386(16): 1532-1546, 2022 04 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35249272
2.
High attack rate in a large care home outbreak of SARS-CoV-2 BA.2.86, East of England, August 2023.
Euro Surveill
; 28(39)2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37768561
3.
Mixture modelling of Bordetella pertussis serology samples to evaluate anti-pertussis toxin immunoglobulin G titre thresholds for positivity: England 2008-2022.
J Med Microbiol
; 72(12)2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38047762
4.
Vaccine effectiveness against hospitalisation estimated using a test-negative case-control study design, and comparative odds of hospital admission and severe outcomes with COVID-19 sub-lineages BQ.1, CH.1.1. and XBB.1.5 in England.
Lancet Reg Health Eur
; 35: 100755, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38115965
5.
Genomic assessment of invasion dynamics of SARS-CoV-2 Omicron BA.1.
Science
; 381(6655): 336-343, 2023 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37471538
6.
Descriptive Epidemiology of Travel and Non-Travel Related SARS-CoV-2 Gamma (P.1/501Y.V3) Variant Cases in England, 2021.
Influenza Other Respir Viruses
; 18(5): e13308, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38736251
7.
Risk of severe outcomes among SARS-CoV-2 Omicron BA.4 and BA.5 cases compared to BA.2 cases in England.
J Infect
; 87(1): e8-e11, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37100176